Send to:

Choose Destination
See comment in PubMed Commons below
Radiother Oncol. 2004 Jul;72(1):79-82.

Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.

Author information

  • 1Department of Radiation Oncology, Ajou University School of Medicine, San 5, Woncheon-Dong, Paldal-Gu, Suwon 442-721, South Korea.


Sensory neural hearing loss (SNHL) was evaluated in the patients who were treated with concurrent chemoradiation therapy for nasopharyngeal carcinoma. Ten from 48 ears showed persistent SNHL. Radiotherapy techniques, radiation dose to inner ear and post-treatment otitis media were significant predicting factors for SNHL.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk